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ABSTRACT 
 
Diabetes mellitus in Sudan is a growing health problem in all socio-economic classes. The natural 
history of the disease is associated with poor of glycaemic control, a high prevalence of complications 
and a low quality of life. 
Objectives: The studies aimed to evaluate the social and economic burden and impact of diabetes. 
The direct costs and intermediate benefits of attaining good glycaemic control were estimated, and 
specifically the contribution by adult patients with type 2 diabetes to manage their disease without 
reported chronic complications, and further to describe and analyse health-related quality of life,  
compared to a matched control group of people without diabetes. 
Design and methods: Four cross-sectional studies using structured questionnaires were conducted in 
Sudan among parents of 147 children with type 1 diabetes and 822 adult patients with type 2 diabetes. 
Data on family and patient incomes, cost of diabetes care and metabolic control of the patients, was 
also obtained, with glycosylated haemoglobin A1c (HbA1c) as determining parameter. Subsequently, 
another 375 people with diabetes were compared with 375 controls using data on out-of-pocket 
medical expenses and social impact. The Health Utility Index was used to assess health-related quality 
of life. 
Results: The median annual expenditure of diabetes care during childhood was USD 283, of which 
36% was spent on insulin. The direct median cost of diabetes care for type 2 adult diabetes patients 
was USD 175 per year. These costs represent 23% and 9% of incomes of the families of the children 
with diabetes and of adult patients, respectively. More than half of the income of adult patients was 
contributed by the spouse or siblings. The median total annual medical expenditure was fourfold 
higher among people with diabetes, compared to those without diabetes (USD579 vs USD148, 
respectively). Moreover, those with diabetes were significantly more likely to suffer from serious 
comorbidities, and reported a higher proportion of personal adverse social effects, such as being 
prevented from doing paid work or participation in education, both for themselves and their families.  
Recall of levels of blood glucose monitoring indicated poor glycaemic control in 86% of children 
with diabetes. HbA1c was at unsatisfactory levels in 77% of adult patients. Patients attending private 
clinics had both higher income and higher costs than those attending public clinics. However, both 
groups had poor glycaemic control, which may reflect the low direct costs and the minimal care given 
to all patients with diabetes. Both self-rated health and the Health Utilities Index were lower in people 
with diabetes, compared with those without diabetes, and were associated principally with pain, visual 
impairment and negative emotions. 
Conclusions and recommendations: These studies have emphasized the intensity of the economic 
burden on Sudanese patients with diabetes. This economic burden has generally not been translated 
into optimum diabetes care, and can be considered as a depletion of family resources and the 
consequences of an inefficient healthcare system. Patients with diabetes and their families pay a 
considerable part of their income to maintain health, and in return they receive insufficient care. The 
implications for health policy are that primary care services should be supported so that patients attain 
better diabetes control, and that the economic burden on patients with diabetes must be alleviated. 
Evidence-based programs for diabetes management and prevention in low-resource communities 
should be developed. Future research is needed to gain a greater understanding both of how families 
cope, and of efficient mechanisms to improve services in a cost-effective way. 
 
 
Keywords: Diabetes mellitus, direct costs, out-of-pocket expenditure metabolic control, low-
income countries, and health related quality of life, Sudan. 
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1. INTRODUCTION 
1.1 Definition of diabetes and classification       
Diabetes mellitus (DM) is a chronic disease that impacts upon the quality of life of an individual 
by hindering the body’s capacity to effectively use energy derived from food. Food is broken 
down into glucose in the process of digestion, and this glucose fuels the body’s metabolic 
activities. For this process of metabolism to occur, glucose is taken up by the cells with the aid 
of insulin that is produced in the beta cells that are found in the islets of Langerhans of 
the pancreas. Diabetes occurs as an inability to produce sufficient insulin that the body requires, 
or as an inability to effectively use the available insulin, and a combination of these two defects 
is common1-3.   
Since insulin is a hormone that regulates blood glucose concentration, alterations in the 
production and utilization of insulin affects blood glucose concentrations. Failure to utilize 
glucose leads to hyperglycemia, or raised blood glucose levels in the body. This condition, if 
untreated can in turn lead to both short-term consequences and also long-term micro- and 
macro-vascular complications. These complications can be experienced by all body systems 
including nerves, eyes, kidneys and blood vessels. There are primarily two clinical classes of 
diabetes, namely type 1 diabetes mellitus (previously called “juvenile diabetes”) and type 2 
diabetes mellitus (previously “maturity-onset diabetes”) 1-3.  
Diabetes mellitus is a growing public health concern that is affecting people globally in all 
countries, and poses a major socio-economic challenge 4,5.  The complications of diabetes that 
arise from poor glycemic control involve the cardiovascular system the kidney, and the eye, 
and chronic diabetic ulcers may additionally lead to amputations of the extremities. These 
effects of diabetes that occur throughout the body systems pose strong challenges to quality of 
life, and may restrain the daily activity of patients 6.  With this state of affairs, patients are 
compelled to suffer from diabetes complications especially in low-and middle-countries, where 
the treatment and management of diabetes is not fully developed 7. These and other reasons 
make diabetes a global epidemic that requires special and immediate attention, both clinically 
and in the public health arena 8-10. 
1.2 Rising burden of non-communicable diseases in low-and middle-
income countries 
Non-communicable diseases (NCDs) contribute to two thirds of all global deaths. They also 
contribute to 40% of all deaths of patients below 70 years of age. Most of these premature 
deaths due to NCDs (82%) are from low-and middle-income countries (LMICs) 11.  This 
implies that these NCDs, in particular stroke, diabetes, ischemic heart diseases and respiratory 
conditions have started to dominate the continuum of causes of mortality in low-and middle-
income societies 12. The increase in prevalence of these diseases is thought to be due to adoption 
of Western lifestyles and urbanization 13. This current trend of events has led to a double burden 
of disease in low-income countries, with both communicable and non-communicable diseases 
being highly prevalent 14. This makes all efforts to prevent this rising trend of NCDs very 
timely, especially in regard to raising awareness of their potential complications and possible 
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modes of prevention. Preventing and treating NCDs has received global attention, and NCDs 
are now referred to as the world’s biggest killers, according to the World Health Organization 
(WHO) 15.  In the case of diabetes, this entails a keen emphasis on timely and early diagnosis 
that would facilitate monitoring and proper glucose control, allied with health education both 
for the patients and health care providers 14.  
NCDs have hampered progress and economic development in low-and middle-income 
countries through their direct impact on the social-economic construction of societies. They 
have become a part of human suffering, and have overwhelmed the capacity and resources of 
health systems in these countries 16. Hypertension alone causes about 9.4 million deaths 
globally every year 17.  It is because of these factors that global targets have been set to halt the 
escalating prevalence of NCDs. One of the global targets for NCDs is to “halt by 2025, the rise 
in the age-standardised adult prevalence of diabetes at its 2010 levels”13page 1513 (line 9-10). The 
prevalence of type 2 diabetes varies greatly between different parts and populations of the 
world, with an average of approximately 3-4% in Sub-Saharan Africa 14. Unlike the situation 
in Africa and Asia, the trend has been mostly constant especially in North-Western Europe. 
Explanations for this could include the rising trend of obesity in these regions, which represents 
one of the major risk factors for diabetes 18.  
A Global Action Plan (GAP) that was designed for the prevention of NCDs to control 
escalating NCD prevalence between 2013 and 2020 has been published by the WHO, and was 
eventually adopted by the United Nations (UN) General Assembly in 2013 15,19,20. One of the 
six objectives of this declaration was to prioritise disease prevention through international 
cooperation, strengthened national capacity for prevention and control, reduced risk factors via 
health promotion, greater people-centred primary health care, promotion and support of quality 
research, and the monitoring of trends and determinants of NCDs. With regards to diabetes, 
resolutions and work plans like this are critical in the face of a rising pandemic, particularly in 
low- and middle-income countries 15,21. The International Diabetes Federation (IDF) estimates 
that 415 million individuals are currently living with diabetes, although half of these individuals 
may not be aware of their diabetes status, and this number continues to increase annually 21.   
1.3 Diabetes is a challenge for health systems  
It was estimated that 5.1 million people died of diabetes and related causes in 2013 alone 22. It 
is currently one of the largest emergencies in terms of global health, and shows an increasing 
prevalence in LMICs. Global figures show an estimate of 415 million adults with diabetes, and 
more worryingly, an additional 318 million adults have impaired glucose tolerance and are 
therefore highly likely to develop diabetes 21. Unlike previous decades, in which infectious 
diseases have dominated the disease burden of Africa, diabetes has become a living reality in 
this context with an estimate of 14 million people having the disease. Projections have shown 
that with a constant trend, this number could double to 28 million by 2030 21. Studies have 
illustrated that this increase will be more pronounced in urban areas 23.  
The major and leading attributes of diabetes, including diet and lifestyle, have been observed 
to change in Africa, with an increasing middle class characterized by minimal physical activity 
and high calorie diets 24. This has led to a rising trend in obesity and subsequently diabetes 25. 
Like other parts of the world, overweight and obesity due to lifestyle change have been 
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identiﬁed as the main drivers of the increasing diabetes statistics in Africa 26. A systematic 
review that was conducted in 2011 on studies performed in Sub-Saharan Africa showed that 
diabetes is highly prevalent, especially in the Northern part of Africa 27,28. 
1.4 The state of diabetes in Sudan 
Diabetes was previously considered a rare condition in Sudan, but this situation has changed 
dramatically in the last four decades, when the trends in prevalence have started to rise. As in 
many other LMICs, the prevalence is estimated to be 8%, but could be even higher in some 
Northern states of the country, reaching figures of about 19% 29 30,31. Although in some cases, 
genetics has a bearing on the illness, a staggering 40% of the cases have been attributed to 
obesity 3. Research has revealed that there is poor glycaemic control in this population, with a 
poor quality of life that is often due to the acute and eventually chronic complications of 
diabetes 32-34. The reasons behind poor glycaemic control in patients may be that treatment has 
been consistent, since most people cannot afford the medicine and treatment is not readily 
available. There were lower attendance rates at in clinics (55%) and non-compliance to dietary 
requirements (79%), since most of the patients never receive diabetes education and care 7. The 
sedentary lifestyle and unhealthy diet that characterize the Sudanese community has made it 
complex environment for preventive measures, but in addition, those with diabetes require 
lifelong treatment that is hard to adhere to in a state where out-of-pocket payments are the 
reality of the day. This therefore affects the daily quality of life of these patients, and hinders 
further progress in these societies 35. 
1.5 Economic burden and impact of diabetes 
The health care system globally has been compelled to bear a heavy toll due to diabetes, and 
this could be due to the associated direct costs required for the medical management, but also 
because of indirect costs with regards to loss of productivity, early and premature mortality, 
and at the same time the loss to a nations’ gross domestic product (GDP) 36 37.  The direct 
medical costs can be very high, depending on the stage and state of diabetes, and entail both 
inpatient and outpatient care, as well as resources for medication and medical supplies 
including all of the consumables required for short term and long term care  37. The major 
bearers of the costs are hospitals and outpatient care systems  37, but these can vary widely 
depending on who bears the cost of payment, i.e., private vs. public modes of payment. 
The multidisciplinary costs associated with diabetes management make it extremely expensive 
to sustain, especially in countries like Sudan, where the finances for health are already 
overwhelmed by communicable diseases. Previous scholars have categorized the economic 
cost of diabetes into direct costs on health care, indirect health care costs, and intangible costs 
38. The costs incurred to buy medicines, supplies like glucometers, hospitalization and 
financing of health care staff are all recognized as direct costs to health care 38. All care that 
may be offered by relatives, friends, as well as nursing homes and productive hours lost that 
could have been spent on work, are referred to as indirect costs 39. The losses in welfare due to 
psychological and physical pain, stigma attached to diabetes and the social costs that burden 
the affected families make up for the intangible costs 40. 
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Because of long distances to health care facilities and waiting times there, patients with 
diabetes in low-income environments have been compelled to lose resources in order to take 
care of their diabetes. It is not surprising that some patients have given up on treatment to 
concentrate on earning a living 40. This financial loss on the individuals subsequently reflects 
in the countries’ economies due to losses in productivity 41. Data concerning this total loss due 
to diabetes in Sudan is limited 41. In 2007, the International Diabetes Federation (IDF) 
estimated the direct costs of diabetes to the healthcare sector in various countries. The study, 
which was based on a model that assumed that the prevalence of diabetes in each country would 
be 6%, concluded that the cost of health care for a person with diabetes is 2.5 times greater than 
that of a person without diabetes 42. 
Several studies have shown that the health care costs related to diabetes are a substantial burden 
on society 43-45. The 2015 version of the IDF Diabetes Atlas estimated global health expenditure 
due to diabetes to be USD 673 billion or INT$795 billion (2011 purchasing power parity) 21. 
Furthermore, a study from the NCD Risk Factor Collaboration calculated global direct costs of 
INT$825 billion (2011 purchasing power parity) for 2014, almost 60% of which arose in 
LMICs, where substantial parts of treatment costs were paid out-of-pocket 13,39.  Boomer and 
colleagues reported estimates of the global direct and indirect economic burden of diabetes, but 
they did not provide a detailed breakdown of costs by country or world region, and did not 
consider all relevant productivity losses for calculation of indirect costs 46. 
1.6 Health-related quality of life  
Diabetes as a chronic disease has both short-and long-term consequences 23. The worry that 
comes with the awareness of hyperglycaemia, coupled with micro- and macro-vascular 
complications, causes a change in lifestyle that may result in a reduction in the health-related 
quality of life (HRQoL). Studies have revealed a reduced HRQoL among individuals with 
diabetes, as compared to their counterparts in similar age brackets without diabetes 47,48.  These 
studies revealed that the quality of life was subsequently reduced with worsening of diabetes 
symptoms and complications 49-52.  In order to compare the differences between individuals 
with varying diabetes duration, and the differences between individuals with diabetes and in 
the general population, a generic instrument is the most appropriate choice. The literature 
supports the use of generic HRQoL instruments for measuring health status in individuals with 
diabetes 53-56. HRQoL can be measured with an ordinary scale or by such instruments as the 
Short Form 36 (SF-36), the Health Utility Index (HUI), and the EQ5D, although many other 
instruments are available 56-60.  There is a lack of evidence concerning the burden of diabetes 
on quality of life among Sudanese populations. To the best of our knowledge, this study is the 
first to analyze the association between diabetes and HRQL in Sudan using the HUI 
instruments.  
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2 BACKGROUND 
2.1 Country context 
Sudan is one of the most geographically diverse and complex countries in Africa. With a land 
area of 1.8 million square kilometres, traversed by the Nile and its tributaries, Sudan shares 
its borders with South Sudan, Central African Republic, Chad, Libya, Egypt, Eritrea and 
Ethiopia. It has access to the Red Sea with an 853 kilometre-long coastline. Its terrain is 
generally a flat, featureless plain, with mountains in the northeast and west, while desert 
dominates the north 61. Its population is highly divided along lines of ethnicity, tribe, religion 
and economic activity. The people in the northern region are Arab-speaking Muslims with a 
diversity of many other indigenous languages 62.  Although fifty-seven years have passed since 
independence, the country appears poorer, hungrier and more divided than ever before, with 
pronounced disparities in the level of development between regions, such that an estimated 
50% of the country’s national income is concentrated in the capital city of Khartoum. The UN 
categorizes Sudan as a low-income, poor and highly indebted country that ranks number 165 
out of 188 countries and territories on the 2016 Human Development Index1. By comparison, 
the country ranked 154 out of 169 countries in 2010 and 150 out of 182 countries in 2009, 
reflecting a progressive trend towards deepening poverty 63. Sudan’s total population is 35 
million, which is growing annually by 2.5%, and is expected to double in 30 years 61. In terms 
of the percentage of the population living below poverty line, Sudan ranks at the bottom, with 
about 47% of the population earning less than 1 US$ a day 63. 
 
Figure 1 Map of  Republic of Sudan 
Source: http://www.mapsopensource.com. 
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2.2 Political landscape  
Sudan is a federally-organized democratic republic with a multi-party system, in which the 
President is head of state, head of government and commander-in-chief of the Sudan People's 
Armed Forces. Both the government and the bicameral parliament - the National Legislature, 
with its National Assembly (lower chamber) and the Council of States (upper chamber) – 
possess legislative power. The judiciary is independent and operates through the 
Constitutional Court 64.  
 
The country comprises 18 states each divided into localities, which in total are 184, but which 
vary with time due to redrawing the boundaries of the existing ones. Sudan has devolved 
certain powers to the states under the Local Government Act (2003), often referred to as the 
Decentralisation Act. However, precise legislative and organisational arrangements may vary 
from state to state. The President, elected through a popular vote, is both the chief of state 
and head of the government. A Council of Ministers appointed by the President runs state 
business, and is responsible to the elected National Assembly. Each state is headed by a 
Governor, elected through a popular vote. The Governor appoints the state cabinet, which is 
responsible to the directly elected state legislature. Likewise, each locality has an elected 
local council. 
2.3 Economy 
Sudan possesses many natural resources, including oil and agriculture. Increased oil production 
in 1999 lead to a boom in the Sudanese economy, and subsequently higher oil prices and a 
significant degree of foreign investment. Despite the presence of sanctions and safeguard 
measures imposed by western countries, Sudan possessed one of the fastest growing economies 
in the world until 2008, with an average annual growth of 5-7% until 2010. However, this 
economic growth was mainly felt in the major cities, leading to increased economic disparity 
between urban and rural areas, and also between the country’s constituent states and 
geographical regions. When southern Sudan gained independence to form the state of South 
Sudan in July 2011, 75% of oil production was removed by the new nation. This resulted in a 
significant impact on government revenues, since oil production corresponded to about 30% 
of the original country’s budget. Furthermore, the independence of South Sudan also impacted 
upon the economic forecasts and the fiscal resources for social services such as health care 65.  
2.4 Health care system  
The health system is divided into three levels of management: the federal level, the state level 
and the locality level (Fig. 2). The federal level includes the planning, coordination, policy-
making and supervising organs, and is exclusively responsible for making partnerships and 
international relations. The state level is concerned with the daily running and implementation 
of policies and service delivery at the hospitals and health facilities. In each of the 18 states of 
the country, the governor (Wali) works as the state administrator, with a cabinet of 5-7 
ministries and 5-12 localities. For every locality, there is a commissioner responsible for its 
administration 65. This top to bottom approach facilitates adequate service delivery to the 
people, although poor resource allocation and uneven distribution of resources among regions 
have rendered the system ineffective. 
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The system also has several partners involved in provision of health care, and especially 
Primary Health Care (PHC). Recently, the Federal Ministry of Health (FMOH) has stipulated 
that the minimum package for PHC services should include: vaccinations of children, the 
Integrated Management of Child Illnesses, as recommended by WHO, reproductive health, 
essential drugs, nutrition, health education, and treatment of common illnesses65. 
 
 
 
Figure 2 Heath care system of Sudan (Source 66). 
 
A number of health challenges put the increasingly ageing population of the Sudan at risk. 
These include rising rates of both communicable and Non-Communicable Diseases (NCDs). 
For example, in the Sudan Household Survey 2011, 26.8% of children of 5 to 59 months of 
age had diarrhea, and 18.7% suffered from suspected pneumonia in the two weeks before the 
survey. In children under 5, protein energy malnutrition and micronutrient deficiencies are a 
major problem, with severe underweight and stunting observed in 12.6% and 15.7% of 
infants, respectively. The most common micronutrient deficiencies are iodine, iron and 
vitamin A 66. Main health status indicators are shown in Table 1. 
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Table 1 Sudan health indicators  
Indicator   
Crude birth rate (%) 33.4  
Crude death rate (%) 17.5  
Total fertility rate (per woman) 4.42  
Life expectancy at birth (years) 63  
Infant mortality rate (per 1000 live births) 51  
Under-five mortality rate (per 1000 live births) 76  
Maternal mortality ratio (per 100 000 live births) 360  
Dependency ratio 96.1  
Source: http://rho.emro.who.int/rhodata 2013 
2.4.1 Healthcare infrastructure 
For the provision of service, health care delivery, as in most countries, is organized at three 
levels: primary, secondary and tertiary care. Health services are provided by the public and 
private sectors (for profit and not for profit). In addition to the federal and state ministries of 
health, the public sector finances the army, the police, the ministries of the interior, higher 
education, and insurance schemes providing health services. 
 
The private sector is growing but is concentrated in major cities, and focuses on curative care. 
Primary care is provided through urban and rural family health centres and units, 
respectively. The public sector operates 3,726 family health centres/units, 141 locality 
hospitals and 55 hospitals 67.  
2.4.2  Human resources for health 
Sudan has a good tradition in the education of health professionals. It has seats of learning, 
such as the University of Khartoum and the University of Gezira, to mention a few. However, 
both a brain drain and migration have impacted on the availability, quality and skill mix of 
the health workforce. The number of health workers has expanded in recent years, although 
it remains below needs-based targets (for example, it is below the 2.3 health worker per 1000 
population target), particularly in the marginalized states/locations 68 . The distribution of the 
workforce is also uneven, i.e., almost 70% of the health personnel work in urban areas, 
serving 30% of the population, with a third of these being in Khartoum. The overall ratio of 
doctors per 100,000 population is 35, with the highest concentration in Khartoum, which has 
55 doctors, while South Darfur has only 3 doctors.  
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2.4.3 Out of pocket payments 
In many health care systems, so-called out-of-pocket payments (OOP; payments by patients to 
public and/or private health care providers at the point of receipt of health care services) 
comprise a substantial part of total health care spending 69. Households use 79% of health 
expenses on curative care, while preventive and dental care receives about 1% each (Fig 3).  
That is, awareness of the importance of these health care activities is low amongst the 
Sudanese population. Nineteen percent of household out-of-pocket expenses are used on 
drugs and medical consumables. This is far below that in 2008, which may be due to better 
data for 2011 health accounts 65.  Direct payments by patients accounted for 70% of total 
health expenditure in 2011, which in effect causes a high financial burden on families 70 .  
 
The high share of out-of-pocket payments in total health expenditure has implications on the 
affordability, equity, and utilization of health care services. For 47% of households, health 
care expenditure had an impact on household income; 14% had faced catastrophic 
expenditures, and had to sell some of their assets. Almost half of the expenditure is made by 
people of the highest quintile (46%), whereas those of the lowest quintile spend only 7% of 
the total  71.  
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Figure 3 Out-of-pocket expenses to Sudanese households by type of service 
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2.5 Health financing system 
The public sector funds 22.3% of total health care resources, while the private sector share is 
73.1%. The rest of the world and/or international assistance contribute 4.5% of financing 
sources for the health care (Fig 4).  According to the national health accounts (2011), 73% of 
funding for health came from private sources, out of which about 70% was out-of-pocket 
health expenditure by households. The public sector funding in 2011 was 15% higher 
compared to 2008. The major financing schemes, in addition to the private insurance market, 
include: the ministries of health, a national health insurance fund, the armed forces employees 
health insurance schemes, and other parastatal institutions.  
 
Table 2 Levels of health funding 
Indicators Value (USD) 
2008 
Value (USD) 
2011 
Per capita total health expenditure. 111 120 
Per capita general government health 
expenditure (GGHE) 
32 27 
Total health expenditure as % of gross domestic 
product (THE / GDP) 
6% 6.4% 
General government health expenditure as % of 
total health expenditure (GGHE / THE) 
28.9% 22.3% 
General government expenditure (GGE) as % of 
GDP (GGE / GDP - fiscal space) 
18.6% 19.0% 
GGHE as % of GGE (GGHE / GGE - fiscal 
space for health) 
8.7% 8.2% 
External funding for health as % of total health 
Expenditure (donor dependency) 
4.0% 4.5% 
 Source: National Health Account, 2008 and 2011 65. 
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2.6 Diabetes health delivery system in Sudan  
Diabetes management is part of the health care system and is integrated at the three levels of 
the health care system. Diabetes is managed in the localities at primary health centres (PHCs), 
which are usually where most of people with diabetes are diagnosed. There are no specialised 
units at the PHCs, and referral of patients is made based on the extent of disease and the 
presence of complications, to the secondary and tertiary units. At the PHCs, initial management 
is performed by medical practitioners who are most often nurses, and these may be assisted by 
locally-trained personnel. Due to scarcity and a lack of readily available equipment and 
personnel, diagnosis is often made using a urine dip-stick, and any complex biochemical 
analyses, including access to HBA1c machines, are only performed in urban centres. Patients 
with glucose in urine are referred to secondary centres that are free of charge, but those that 
can afford the choice are given the option of private clinical care at a cost. Most patients with 
diabetes are attended to by either the primary health care centres or by the private clinics. 
Sudan has ten specialists in diabetology, who are located at the tertiary centres, eight of whom 
are found in Khartoum state. These individuals are also part of the teaching hospitals, and each 
outpatient clinic at the tertiary institutions is headed by a diabetologist, although resident 
doctors and medical officers are also involved in outpatient management at the tertiary centres. 
This highlights the fact that there are endless shortages of attending health workers, due to the 
different roles that they play at the hospital, in addition to the fact that more and more emigrate 
to other countries for better wages and opportunities. 
At outpatient clinics, patients are usually stabilised and monitored for complications. Despite 
this organisation, there is no follow-up system for patients, neither are there any formal home 
visits for follow-up. In addition, there are also three stand-alone ‘public’ diabetes care centres. 
These are supervised by the Ministry of health, but the mode of payment is a user fee system. 
There are also three private diabetes care centres, which are also supervised by the Ministry of 
health, but the mode of payment is out-of-pocket. This system of referral applies for both 
children and adults, and the tertiary institutions are usually equipped with the laboratories for 
easy monitoring of control and possible complications. Systemic complications that require 
either medical or surgical interventions are managed through the referral systems at the tertiary 
institutions.
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3 AIMS OF THE STUDY 
3.1 Aims and objectives 
The aims of this study were to evaluate the social and economic burden and impact of diabetes 
mellitus on patients and their families in Sudan, and further to describe and analyse health-related 
quality of life, compared to a matched control group of people without diabetes. 
The specific objectives were: 
1. To estimate direct costs of care for children with type 1 diabetes, and to assess their 
glycaemic control (I).  
 
2. To estimate the direct costs of care in patients with type 2 diabetes, and to estimate those 
costs in relation to the patient’s income and to the level of diabetes control (II).  
 
3. To examine the economic and social impact attributed to diabetes in Sudan by calculating 
out-of-pocket medical expenditure and the health and social impact of the disease for 
persons with diabetes and their families (III). 
 
4. To describe and analyse HRQoL in patients with diabetes, compared to control 
individuals matched for sex, age and region (IV). 
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4 METHODS     
The provision of high-quality, affordable health care services is an increasingly difficult 
challenge. This thesis focuses on investigating and interpreting healthcare utilization, the cost of 
medical care, HRQoL and the social impact for individuals and populations. It is a cross-sectional 
examination of four diabetes studies with elements of case-control analyses in two studies.   
4.1 Study context 
Descriptive studies I and II were performed in the state of Khartoum in Sudan. Khartoum State 
serves as the capital city and the commercial centre of Sudan. The confluence of the White Nile 
and the Blue Nile forms the natural separation of the three towns: Khartoum, Khartoum North 
and Omdurman. With 20% of the country’s population, Khartoum has 6 million inhabitants. The 
state has a relatively higher level of healthcare compared to elsewhere in the country. Most 
healthcare services have relatively adequate numbers of practitioners and specialists.  Study I was 
conducted among the parents of children with type 1 diabetes. The second study (II) was 
performed among patients that had type 2 diabetes.  
Studies III and IV were performed at outpatient diabetes clinics, and compared patients with 
diabetes to those without in a case-control study. These individuals were from the same area of 
residence and were matched based on age and sex. These last two studies (III and IV) were 
conducted in four states in different parts of Sudan: Al Jazirah, Darfur, Khartoum and Sennar. Al 
Jazirah is located between the Blue Nile and the White Nile in the eastern–central region of the 
Sudan. Darfur is found in the western part of Sudan, whereas Sennar is located in the south-
eastern part of Sudan. Each of the selected states has a diabetes centre, and these four centres 
deliver services to more than 70% of all patients receiving diabetes care in the study area. 
4.2 Study population  
Information regarding the study was given to all parents of children with diabetes and to those 
adults that had diabetes. This invitation to participate in the study was made once every week at 
each of the facilities. In study I, 147 (90%) of the identified 164 children agreed to participate and 
attended the scheduled appointments for the interviews.  
In study II, patients above 30 years of age, who had had type 2 diabetes for a duration of between 
one year and five years, were invited to participate, and 822 of such patients who were attending 
public or private diabetes clinics agreed to participate and were interviewed. The patients, who 
agreed to participate, represented 92% of the total attendees for the clinics on those particular 
days. This gave a representative sample for Khartoum state, and could equally be comparable to 
other urban areas in the country. In all, 52 and 71 adults were randomly selected from public and 
private clinics, respectively, which made a total number of 123 adults with diabetes. From these, 
venous whole blood samples were drawn in EDTA-containing tubes for the HbA1c test. The data 
for statistical power calculations for an economic study in sub-Saharan Africa are not available. 
For study III and IV, 375 cases and controls were recruited, and these were representative of the 
population and helped to minimize the variations due to the outliers. This sample size gave a 
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statistical power of greater than 90% to detect a difference in proportions of 10 percentage points 
or larger at an alpha of 0.05. For the purpose of the present study, this understanding was applied 
to gain access to the health quotient of the population.   
4.3 Data collection  
4.3.1 Procedure 
Study I and II were conducted in two main hospitals in Khartoum State, i.e., Khartoum and 
Omdurman Teaching Hospitals plus Jabir Abu Eliz (the only public diabetes centre in Khartoum 
State), Mulazmin Diabetes Center (a private centre) and at private diabetes specialist clinics. 
These deliver care to patients with diabetes in Khartoum State. The first two sub-studies presented 
in this thesis consist of interviews with children’s parents and adult patients with diabetes who 
were these attending public and private diabetes clinics. Glycosylated haemoglobin (HbA1c) was 
used as a measure of glycaemic control, and was determined in samples randomly collected from 
the adult patient cohort.  
For studies III and IV, patients that attended the diabetes clinics were asked for informed consent 
and those that agreed were subsequently scheduled for individual interviews. The controls for 
these studies were concurrently recruited and were matched by age (within 5 years) and sex (male 
or female). These controls were individuals who had no self-reported history of diabetes or 
diagnosis of diabetes by a physician. These were either individuals accompanying those that were 
attending the diabetes clinic, or those that resided in the same geographical area, and this process 
of recruitment took place within 48 hours of recruiting the index cases. These controls were 
subjected to a questionnaire identical to that of the cases, and there was one control for each 
completed case interview.  
During the process of recruiting the cases with diabetes, the patients with diabetes were requested 
to suggest five persons living closest to them who were of the same age (±5 years) and sex. This 
provided potential clues and information about controls that were later contacted. The names of 
the controls that were suggested were randomly ordered on the list of five and each of these 
individual’s households were approached in that order, either through phone calls or direct 
household visits. Those that were found at home and were willing to be interviewed were 
recruited immediately, otherwise a meeting at a later date was scheduled. In case the intended 
individual was not reached, another control who was next in line was chosen according to the 
order they appeared. The interviewers never left the locality until they found a potential control, 
and in the case that all the five possible controls were not forthcoming, other possible controls 
were sought from the same area. 
4.3.2 Questionnaires 
A semi-structured questionnaire was used for studies I and II to interview both the parents of 
children with diabetes and the adults with diabetes. Information was gathered regarding 
metabolic control and frequency of episodes of hypoglycaemia and hyperglycaemia. The 
interviews also included collection of data on socio-demographic characteristics, and school 
performance of the children with diabetes before and after the diabetes diagnosis. Family income 
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both for the children with diabetes and adult patients in the previous month and year were also 
obtained.  For the adult patients, income contribution for the spouses and siblings was also 
obtained.  
The respondents were asked to state their income by stating all the income that they had received 
in a given period. The noted sum was converted to US dollars, and rounded off to the nearest 
whole dollar. The family’s health expenditure on diabetes for both children and adults was 
obtained for a 24 hours, and for periods of 3 months and one year. All information on the costs 
of insulin, syringes, drugs, urine and blood tests, as well as the number of visits to doctors, and 
the number and length of hospital stays during these periods, was obtained.  When a case or a 
control subject was unable to speak, or had insufficient recall to complete the interview alone, 
the involvement of surrogate respondents was permitted. In such cases, the interviewer 
requested the surrogate family member to respond to the survey questions on the subject’s 
behalf.  
A predefined questionnaire (the research tools developed by the International Diabetes Federation 
(IDF)) (appendix I) was used for studies III and IV. This questionnaire gathered information about 
the use of medical services, payments made for medical care services, cost of medicines and 
acquisition of these medicines. The costs also included costs of medicines and medical care for 
hyperglycaemia, dyslipidaemia, hypertension, and in-patient and out-patient hospital expenses.  
The interview asked about expenses in the previous 90 days in order to reduce recall bias i.e. 
patients were asked to name and associate a well-remembered event that had occurred 
approximately 90 days previously.  
4.3.3 Responders and non-responders  
If it proved impossible to complete an interview once it had begun, and it could not be completed 
on another day, this case or control were removed from the study sample and replaced with 
another person per protocol. The interviewer terminated the interviews of all control subjects who 
said that they had been diagnosed with diabetes, or whenever in the interviewer’s judgment the 
subject was not responding truthfully or accurately, or no longer wished to participate in the study.  
4.4 Outcome measures 
4.4.1 Costs 
The participants were asked about the medicines they had bought in the last 90 days in order to 
estimate their expenditure on medicines. For the patients that were admitted overnight to hospital, 
they were asked to recall their total point-of-service payment. This included charges for medicines 
and tests that were done and in case there was any out-of-pocket payment. The fees paid at the 
hospital entail all charges on medication and these were eventually used to determine length of 
stay and means of payment during each admission. The visits that were made by participants to 
the other providers like the specialist doctor or surgeon, primary care doctor, nurse, traditional 
healer (including herbalists and fortune tellers, magicians, and oracles), pharmacist, dispensary, 
visit to a clinic to collect medication, health educator such as a diabetes educator, or community 
 16 
health worker, were calculated separately. This method was also used to calculate the expenses 
at the emergency room and the impatient stay in the hospital.  
The average daily price was calculated using data on the most recently purchased item i.e. the 
number of pills or units of insulin purchased at that time, and the number of pills or units 
prescribed per day. We then multiplied this result by an adjuster for self-reported adherence, the 
average number of days per week that the participant indicated that he or she adhered to the 
prescribed regimen for a given medicine, divided by seven. This gave us a payment per day as 
used. Mean daily payments were multiplied by 365 to obtain an annual mean expenditure. All the 
currencies reported here are in USD, and the conversion rate applied was the one that was used 
at the time of the data collection by the central bank of the Sudan (1USD = 4.30 SDG). 
4.4.2 Health-related quality of life 
HUI3 is a multi-attribute utility measure that defines health states according to eight attributes 
(vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain), with five or six 
levels of functioning for each 72. Overall scores on the HUI3 range from -0.36 (the worst possible 
HUI3 health state) through 0.0 (dead) to 1.0 (perfect health) 72. Single-attribute utility scores range 
from 0.0 (lowest level of functioning) to 1.0 (full functional capacity). Differences of 0.03 or 
more in overall HUI3 scores and 0.05 or more in single-attribute utility scores are considered to 
be clinically important 60. The construct validity of HUI3 in large, representative samples lends 
support for the use of HUI in studying HRQoL among people with diabetes 73,74.  
4.4.3 Laboratory analysis 
Glycosylated haemoglobin analysis was conducted using high performance Liquid 
chromatography. The level for acceptable glycaemic control was <6.5%, which concords with 
the recommendation from the European Diabetes policy group. 
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4.5 Data analysis 
 
Table 3 Overview of statistical tests performed in the four studies 
Study 
Variables1 Chi-square / 
Fisher’s text* 
Independent samples t-
test 
Mann-Witney U 
test 
Regression McNemar two-
sided change test 
I Cost of health care 
utilization, visit to 
different types of health 
care facilities, income 
 Compare mean income 
and cost between parents 
attending private & public 
clinic 
  Test metabolic 
control with 
school 
performance and 
parents education 
II Cost of health care 
utilization, and 
monitoring and treatment 
of diabetes 
 Glycaemic control 
between males and 
females 
Testing the 
difference of 
Income and cost 
between groups 
  
III Cost of health care 
utilization, case/control, 
sex, age, marital status, 
level of education 
Socio-economic 
characteristics 
Comparison of 
health conditions and 
social impact  
of patients and their 
families  between cases 
and controls 
Comparison of 
mean expenditure 
between different 
groups among 
cases and controls 
  
IV HRQoL, index 
case/control, sex, age, 
marital status, level of 
education 
Socio-economic 
characteristics 
Mean difference in HUI3 
index between  cases and 
controls 
 Associations of 
HUI3 Index with  
diabetes diagnoses 
and demographic 
characteristics 
 
1DV=dependent variables, IV=independent variables * 
2For all the studies, data was analysed using SPSS 75 
 
In studies I, II, and III, results are presented as mean  SD, or as median and interquartile range. 
Pearson’s chi-square test, Fisher’s exact test, Student’s t-test and the McNamara two-sided 
change test were used for evaluation of statistical significance. In study IV, differences between 
pairs of groups were tested by Student’s test and Mann-Whitney’s U-test. The independent 
samples t-test was used to verify whether there were differences in the mean HUI3 index between 
individuals with diabetes and control individuals. In all tests, P0.05 was defined as being 
significant. The confidence intervals (CI) were calculated for percentage of unsatisfactory results 
in blood glucose level, compared between public and private patients.   
 
In study III and IV, data were analysed using SPSS 75 a descriptive analysis was performed for 
all variables and unadjusted comparisons between case and control were made using a T-test (for 
continuous variables) or a chi-square test (for discrete variables). When appropriate, longitudinal 
models were created for outcome variables. All data were presented before and after adjustment 
for confounders and interactions. Basic presentations of data included number and percentages of 
cases with diabetes by age, sex, location of residence, and in relation to different known risk 
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factors. The Chi-square test was used to assess the association between diabetes and different risk 
factors.  All statistical tests were carried out at the 5% significance level. 
 
In study IV the main outcome measures were the self-reported health quotient as expressed in the 
HUI, the HUI mark three index and the global self-rated health (SRH) parameter. The HUI index 
was calculated by averaging the preferences of the community. The preference scores were 
measured as per the utility function. To test whether there was a difference in socio-demographic 
characteristics between individuals with diabetes and control individuals, as well as the 
percentage of reported problems in the HUI3 attributes, multivariable regression analysis was 
performed to identify the independent variables (sex, age, diabetes diagnosis, the level of 
education, employment status, and region) that could explain the variation in the dependent 
variable HUI3 index. 
4.6 Ethical consideration 
For all the four studies, ethical approval was sought and obtained from the Ministry of Health in 
Sudan, and from the Ahfad University for women. Study I and II were also assessed by the Ethics 
Committee of Karolinska Institutet, Stockholm, and there was no objection. Through the use of 
consent forms, participants were informed about the purposes and objectives of the study and 
those that verbally expressed willingness to participate were recruited. Participants received both 
written and verbal information about the study. Confidentiality was assured to the participants, 
and they were informed that their participation in the project would not change their treatment at 
the clinic. The participants were given assurances that they could leave the study at any time for 
any reason, and they would not be asked to disclose a reason for this. No incentives were provided 
to any of the participants, and they agreed to participate for scientific reasons. The interviewers 
that were involved were trained by the primary investigator following instructions by the IDF.  
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5 RESULTS  
5.1 Patient characteristics and family income 
In Study I, the estimated mean annual income of the households of children with diabetes was 
USD 1810; nevertheless, due to the skewed distribution, the median household income was 
estimated as low as 1222.  In the quartile of families with lowest income, the annual income 
was less than USD 600. In this study, we considered income as permanent revenue like salaries, 
but also temporary sources of income, generally donations from relatives and friends, were 
included.  These temporary sources accounted for 16% of the mean total family income. From 
those families of children with diabetes, those who attended private clinics had significantly 
higher mean salaries than those who attended public clinics (USD 56, p<0.03), although there 
was no significant difference in total income between the two groups.  
In study II, besides personal income, we included contributions from other sources, which 
mostly were from the spouse and siblings. The median annual income was estimated as being 
USD 1923.  Patients over 60 years of age had an average annual median income of USD 1923, 
which was more than in those below this age (USD 1846, p<0.05).  The proportion of income 
received by the older age group of patients from their siblings or relatives was significantly higher 
(USD 1265) than that received by the younger age group (USD 1135, p<0.01). However, the 
nuptial economic input received by the females was significantly higher than the one received 
by the males from their partner (p<0.01). The same was true for sibling contributions, thus 
making the total average income of females not significantly lower than that of males. Those 
patients who attended private clinics had a higher median income than those who attended 
public clinics. 
Income seemed to have a clear impact on the behaviour of seeking medical treatment for 
patients and their families in patients with type 1 and type 2 diabetes. This is reflected by our 
finding that the mean income of patients attending private clinics was significantly higher than 
of those attending public clinics. This gives an indication of the patients’ ability to pay, as we 
expect the cost of treatment to be higher in private clinics, relative to public ones.  
For study III & IV, interviews were completed by 375 persons with diabetes (75% response 
rate), who were included in the final dataset together with their 375 controls. The mean age was 
50 years; 61% were women and 44% lived in Khartoum state. Case participants had a lower 
education level, but the same employment status as controls (Table 4). There were no 
differences between people with diabetes and individuals without diabetes except for marital 
status. Case participants were significantly less likely to be married or cohabitating compared 
to control participants (67% vs. 75%). (Table 4).  The majority of diabetes patients had had 
diabetes for five years or more. It is important that people have an early diagnosis of diabetes 
for several reasons, for example, knowledge of the presence of glucose intolerance makes it 
possible to stop the progression of the disease and its consequences. 
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Table 4 Demographic characteristics people with diabetes (n=375) and control individuals 
(n=375) 
 Diabetes patients  Control individuals 
 n=375 (%)  n=375 % 
Sex Male 147 (39)   147 (39) 
Female 228 (61)   228 (61) 
              
Age group (years) 20-39 61 (17)   70 (19) 
40-59 197 (53)   216 (58) 
60 and above 114 (30)   89 (24) 
              
Marital status Single 56 (15)   41 (11) 
  Married 248 (66)   279 (74) 
Widowed 56 (15)   40 (11) 
Separated or Divorced 13 (3.5)   14 (3.7) 
Cohabiting 2 (0.5)   1 (0.3) 
            
Education level Unfinished primary school 166 (44)   130 (35) 
  Finished primary school 85 (23)   102 (27) 
Finished secondary school 71 (19)   82 (22) 
University students 15 (4)   17 (4.5) 
Finished university 38 (10)   44 (12) 
            
Employment status Employed 118 (32)   132 (35) 
  Unemployed/Not working1 104 (28)   91 (24) 
Retired or pensioner 31 (8)   43 (12) 
Housewife 111 (30)   96 (26) 
Student 11 (2.9)   13 (3.5) 
            
Region Khartoum 166 (44)   166 (44) 
  Other states 209 (56)   209 (56) 
            
Duration of diabetes 1-4 years 124 (33)   NA NA 
5 years or more 251 (67)   NA NA 
                1Not working due to health problems. 
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5.2 Expenditure on health  
In Study I the family expenditure on health for the previous years showed that 65% of the 
resources was spent on the child with diabetes, where the older took 16% and the younger 
sibling 5% of the total health expenditure.  
The total median direct cost of diabetes care was USD 283, from which more than 1/3 was used 
for insulin. Families of children with diabetes who attended private facilities showed a 
significantly higher total expenditure on health services and glucose tests than the families who 
attended public health facilities (Table 5). During the previous six months, children with 
diabetes had attended a practitioner’s consultation six times on average. The recall showed that 
the mean frequency of visits of patients to doctors in public health centres (6.4+5.0) (mean + 
S.D) was significantly higher than that to doctors in private centres (4.9+4.4, p<0.05).  
 
Table 5 Cost of diabetes care for parents of children with diabetes attending public and private 
health centers 
Expenditure Public health 
 centres* 
Private health 
centres* 
P-value 
 
Insulin  109 74 
 
123 73 
 
N.S.** 
Urine test    40  36 
  
  34  25 
 
N.S. 
Blood test for 
glucose 
  43  69 
 
121  214 
 
0.01 
Hospital admission  102  160 
 
  75  57 
 
N.S. 
Doctor fees   87  108 
 
  80  101 
 
N.S. 
Total cost 378  162 
 
435  267 0.01 
         *Data (mean  SD) are expressed in USD. ** N.S. Not significant 
 
 
 
In study II, 73% of the total number of patients had received ambulatory care in private clinics. 
During the last six months, 85% of patients visited their doctor more than twice. The annual 
median direct cost of diabetes control, including ambulatory care and drugs, was USD 175. 
Patients with diabetes who used private clinics had a significantly higher average expenditure 
on diabetes control than those who used public clinics. The cost of ambulatory care (doctor’s 
fees and cost of investigations) was specifically higher for private facility users (USD 147) than 
for public facility users (USD 79) (p<0.01). Those patients with diabetes who were 60+ years 
old had significantly higher expenditure on ambulatory care items than the younger patients, 
excluding drugs  (USD 159 vs. USD 135; p<0.01).  
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Males older than 60 years spent significantly more than those younger than 60 years on total 
diabetes care, while older females spent significantly more on ambulatory care (doctor’s fees 
and investigations) than younger females (Table 6). The results showed that in patients 
attending public clinics, there was no significant difference in the cost of diabetes care between 
different age groups. However, for patients older than 60 years of age and attending private 
clinics, the cost of diabetes care was higher than for those of less than 60 years of age. 
 
Table 6  Median (interquartile range) annual cost of diabetes care in USD for age groups and 
divided by sex 
Categories 
 
Item   
Age Group 
yrs  
Males  
N = 331 
P- value  Age Group 
yrs  
Females  
N = 491 
P- value 
Diabetes 
drugs 
30 - 60 
 
97 (55 -162) 
ns 
30 - 60 
 
92 (55 -208) 
ns 
>60 
 
115 (69 -335) >60 
 
92 (56 -139) 
Ambulatory 
care 
(Out-
patient) 
 
30 - 60 
 
119 (69 -199) 
ns 
30 - 60 
 
144 (89 – 197) 
0.05 >60 154 (83 -211) >60 159 (105 - 203) 
Total cost of 
Diabetes 
control 
30 – 60 
 
139 (73 - 211) 
0.001 
30-60 
 
175 (107 – 262 ) 
ns 
> 60 
 
192 (116 - 308) > 60 
 
192 (149 - 264) 
 
 
 
Table 7 Median (interquartile range) annual cost of diabetes care in USD for age groups and in 
relation to private and public clinics 
Categories 
 
Item   
Age Group 
yrs  
Attending 
public clinics 
N = 69 
P- value  Age Group 
yrs  
Attending 
private clinics 
N = 753  
P- value 
Diabetes 
drugs 
30 - 60 125 (51- 314) ns 30 - 60 92 (55- 190) ns 
>60 92   (62- 505)  >60 92 (55- 185)  
Ambulatory 
care 
(Out-
patient) 
 
30 - 60    92  (41- 140) 
 
ns 30 - 60 142 (82- 200) 0.006 
>60    159  (49- 88) 
 
 >60  147 (106- 212)  
Total cost of 
Diabetes 
control 
30 - 60    98   (42- 213) 
 
ns 30 - 60 169  (97- 242) 0.001 
> 60 192 (73- 316)  > 60 177 (138- 287)  
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The median and quartiles in study III were reported together with the mean, since the data on 
cost was skewed. The median annual medical expenditure for the case participants was four 
times higher than for the control participants. This medical expenditure included costs for in- 
and out-patient services plus the cost of medicines used. The participants with diabetes had a 
mean expenditure that was 85% higher than that of participants without the disease (USD 1004 
vs. USD 544). The expenditure on out-patient services for case participants was almost nine 
times higher (USD 345 vs. USD 40) and almost ten times higher for medication (Table 7). This 
difference in expenditure was similar for women and men. The case participants spent 
significantly more on medical costs across all the three age groups (20-39 years; 40-59 years; 
60-79 years), in comparison to the control participants. For the age group 20-39 years, the case 
participants had a higher cost for out-patient services and medicines, in comparison to the 
respective control group. More than half (59%) of the case participants with diabetes reported 
the lack of economic resources required to cover the cost of care as a reason for not receiving 
regular medical services, and 48% of the case participants that were on insulin therapy reported 
inability to afford the treatment.
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Table 8 Comparison of annual mean expenditures on in-patient hospital services, out-patient clinics, medicines, and total costs between 
persons with diabetes (cases) and individuals without diabetes (controls) 
  Inpatient expenditure (US$) Outpatient expenditure (US$) Medication expenditure 
(US$) 
Total expenditure (US$) 
  Cases Controls P-
value 
Cases Controls P-
value 
Cases Controls P-value Cases Controls P-
value 
Total     <0.001     <0.001     <0.001     <0.001 
Mean ± SEM 247 ± 54 143 ±37   657 ± 47 345 ± 35   101± 9 56 ± 8    1004 ± 72 544 ± 64   
Median (IQR) 0 (89) 0 (0)   345 (771) 40 (396)   59 (131) 6 (65)   579 (973) 148(597)   
Male     <0.001     <0.001     <0.001     <0.001 
Mean ± SEM 253 ±73 167 ±75   670 ± 75 320 ± 56   107 ± 16 60 ± 18   1030 ± 
102 
546 ± 98   
Median (IQR) 0 (42) 0 (0)   119 (774) 25 (316)   58 (131) 0 (65)   536 (1009) 132(596)   
Female     0.001     <0.001     <0.001     <0.001 
Mean ± SEM 243 ±50 128 ±38   649 ± 
590 
361 ± 47   97 ± 10 53 ± 7   989 ± 98 542 ± 83   
Median (IQR) 0 (95) 0 (0)   407(774) 45 (453)   62 (130) 7 (66)   635 (908) 163(617)   
Age 
groups(years) 
  
20–39     0.005     <0.001     <0.001     <0.001 
Mean ± SEM 309±111 165 ±72   781 ±150 259 ± 66   101 ± 15 45 ± 11   1192 ± 
173 
469 ±110   
Median (IQR) 0 (236) 0 (0)   429 (843) 0 (178)   70 (106) 0 ( 49)   844 (999) 77 (419)   
 40–59     0.001     <0.001     <0.001     <0.001 
Mean ± SEM 229 ±84 132 ±71   623 ± 55 358 ± 53   97 ± 11 60 ± 13   950 ± 103 551 ± 93   
Median (IQR) 0 (86) 0 (0)   352 (753) 32 (326)   58 (108) 7 (65)   563 (858) 135 (561)   
 60–79     0.021     <0.001     0.010     <0.001 
Mean ± SEM 243 ±83 152 ±90   645 ± 83 381 ± 63   106 ± 19 55 ± 9   994 ± 117 589 ±109   
Median (IQR) 0 (23) 0 (0)   287 (698) 109(572)   58 (152) 15 (73)   477(1123) 206(662)   
1.         P-values were calculated using the Mann–Whitney U-test because the variables were not normally distributed and are given for comparisons between 
case and control participants. 
2.         IQR, interquartile range= difference between median values for quartile 3+4 versus quartile 1+2 
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5.3 Diabetes control and acute complications  
Responses from the parents of children with diabetes (Study I) showed that the most frequent 
pre-meal or fasting blood glucose levels during the last 6 months were unsatisfactory in 86% 
of the cases. Their most frequent pre-meal blood glucose level was 9 mmol/l or higher. 
However, it was noted that 26% of the study group had not tested their blood glucose during 
the last six months. There was a negative correlation between the mother’s educational level 
and the fasting blood glucose level of children with diabetes (p<0.02), but the father’s 
educational level was not of significance. There was no correlation between the parents’ income 
and glycaemic control, nor was there a difference in diabetes control between children attending 
private and public clinics. Acute complications of diabetes, as evidenced by ketone bodies in 
urine, were reported in 46% of the children. Hypoglycaemia that needed special attention had 
occurred in 37% of the patients, and 57% had been admitted at least once to the hospital within 
the last year, the main causes of admission being diabetic ketosis (72%), hypoglycaemia (6%), 
malaria (11%) or other medical disorders or surgical interventions (9%). 
Adults with type 2 diabetes (Study II) did not show better outcomes, in comparison with 
children with diabetes. Glycosylated haemoglobin or HbA1C was determined to be 
unsatisfactory (HbA1c more than 6.5%) in 77% of patients (Mean + SEM: 8.2 + 0.12). On 
recall of the most frequent blood glucose levels in the last 3 months, fasting blood glucose levels 
of 4.4-6.7 mmol/L were reported by 15% of patients. However, almost two thirds reported 
fasting blood sugar levels of more than 8.9 mmol/L. There was no significant difference in the 
reported levels of fasting blood glucose during the last three months between males and 
females. 
Of the patients studied, 81% performed their blood and urine tests in private laboratories, 7.5% 
visited public laboratories and 2.3% conducted their tests using both facilities. Home Blood 
Glucose Monitoring (HBGM) was carried out by only 9% of the patients, with no gender 
difference. Only 11% of patients who were conducting HBGM had tested their blood for 
glucose more than three times during the previous months. Patients who needed special 
attention to control hypoglycaemia accounted for 16% of the study population. Regarding 
complications, 25% of the patients had had hospital admissions during the previous year. Of 
these, 37% had acute infection and ketosis, 8% had hypoglycaemia, 13% had malaria, 35% had 
surgical causes and 7% had other complications and causes for in-patient treatment. In Study 
III, a higher prevalence of co-morbidities was reported among the case participants, and these 
included erectile dysfunction or loss of libido, hypertension cardiac diseases, kidney disease, 
foot or leg ulcers, peripheral neuropathy and depression (Table 9).  
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Table 9 Comparison of reported health conditions as told to a doctor, for persons with diabetes 
(cases) and those without diabetes (controls) 
1Pearson’s chi-square comparison test between cases and controls 
 
 
 
 
 
 
 
 
 
 
 
 
Cases 
n =375 
Controls 
n =375 
 
n % n % P-value1 
Heart attack, heart failure or 
 other heart disease 
36 9.6 14 3.7 0.001 
Stroke 13 3.5 10 2.7 0.51 
High blood pressure 124 33 98 26 0.03 
Asthma or other lung disease 56 15 48 13 0.40 
Erectile dysfunction or loss of libido 36 8.5 14 2.8 0.001 
Kidney disease 37 9.9 18 4.8 0.01 
Peripheral neuropathy 156 42 33 8.8 <0.001 
Foot or leg ulcer 34 9.1 4 1.1 <0.001 
Amputation of toe, foot or leg 30 8.0 5 1.3 <0.001 
Eye surgery 38 10 24 6.4 0.063 
Laser treatment for eyes 31 8.3 11 2.9 0.001 
Depression 68 18 28 7.5 <0.001 
Other permanent problem  53 14 58 16 0.61 
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5.4 Social impact 
In study I, school performance reported by parents showed a significant deterioration among 
children with diabetes from the onset of diabetes to the current date (p < 0.001).  For Study III, 
case participants were significantly more likely to report a negative impact on all social 
indicators (Table 9). As a result of their diabetes, 21% of the individuals reported being 
prevented from doing any work, or as much paid work as they would like (controls: 6.1%). 
There was a similar impact on family members of the case participants (Table 9). There was a 
significantly higher likelihood of limited ability to grow food, do farming and housework for 
case participants and their families, compared to controls, and these case participants were five 
times more likely to report being prevented from enrolling in training or school due to their 
diabetes (8.5% vs. 1.6%), and hence limiting their future income. About one third (32%) of the 
case participants reported not getting enough to eat compared to the controls (8.5%). For the 
family members of the case participants, 20% reported lack of enough food to eat (controls: 
6.9%) (Table 10). 
 
Table 10 Proportion of persons with diabetes (cases) reporting that their health problems were 
affecting their or their family members' lives compared with control participants 
 Cases 
n=375 
Control 
n=375 
 
n % n % p-value1 
Prevented or kept from doing any paid work or doing as much paid work as 
wanted 
77 21 23 6.1 <0.001 
Having done more paid work than would do otherwise 32 8.5 8 2.1 <0.001 
Family member prevented from doing work or kept from doing as much paid 
work as wanted 
67 18 40 11 0.005 
Family member having to do more paid work than wanted 84 22 57 15 0.012 
Prevented from growing any food or doing any work in the house or kept 
from doing as much farming or housework as wanted 
86 23 26 6.9 <0.001 
Family member prevented from: growing any food; doing any work in the 
house; or doing as much farming or housework as wanted 
55 15 37 10 0.045 
Prevented from enrolling in school or training 32 8.5 6 1.6 <0.001 
Family member prevented from enrolling in school or training 62 17 36 10 0.005 
Kept from getting enough to eat 120 32 25 8.5 <0.001 
Family member kept from getting enough to eat 74 20 34 6.9 <0.001 
1 Pearson’s chi-square comparison test between cases and controls 
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5.5 Impact on health and health-related quality of life  
5.5.1 Reported problems in HRQoL  
Twenty-six percent of the case participants reported less than good self-rated health (SRH), in 
comparison to 12% of control individuals (p<0.001). People with diabetes had a multi-attribute 
index HUI of 0.61 (SD 0.31), compared to 0.79 (SD 0.20) for control individuals (p<0.001). 
People with diabetes reported more problems, and increased levels of severity, in the different 
HUI3 attributes, compared with control individuals (Table 10). These included pain, visual 
impairments, and emotional problems. Problems related to hearing, mobility and hand functions 
were significantly different among the two groups. For the participants with diabetes, the lowest 
single attribute HUI index was found in the attribute pain (0.90) followed by emotion (0.91), 
while the same figures for control individuals were 0.95 and 0.94, respectively.  
5.5.2 Influence on HRQoL 
The HUI score was used as the main outcome measure in the multivariable regression analysis 
(Table 11).  Sex, being 40 years of age or older, and being diagnosed with diabetes, had a 
negative significant impact on the HUI3 index in the full regression model, while being a 
housewife or widowed had a significant positive impact on the HUI3 index. There were no 
significant differences regarding level of education or area of residence (whether the individuals 
lived in Khartoum or other regions). Regression was done for two separate groups to determine 
whether there was a difference in HRQoL for people with diabetes and control individuals 
(Table 12). For the participants with diabetes, being 40 years of age or older negatively 
impacted on the HUI3 index, while being a housewife had a positive impact. Being 60 years of 
age or older, as well as being retired, had a negative impact on the HUI3 index for the control 
participants. According to sex, regression revealed that men with diabetes who were 40 years 
of age and older had their HUI3 negatively impacted, while this happened later in women at 
age 60 years and older (data not shown). 
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Table 11 Frequency distribution (percentages) of HUI3 attribute levels and single level attributes, comparing people with diabetes (D) and people 
without diabetes (C) 
 
Attribute 
levels 
Attribute (HUI3) 
Vision*  Hearing*  Speech  Mobility*  Hands*  Emotion*  Cognition  Pain* 
D C  D C  D C  D C  D C  D C  D C  D C 
1 42 60 90 94 99 99 87 92 88 95 28 44 59 62 39 54 
2 40 38 6.7 5.1 0.8 0.8 10 7.7 3.5 2.7 38 40 7.7 8.0 14 19 
3 4.0 1.1 0.5 0.5 - - 1.6 - 0.5 - 22 10 19 20 27 22 
4 9.3 1.6 1.1 0.3 0.3 - 0.3 - 4.5 1.6 12 5.6 12 8.8 9.6 3.2 
5 2.1 - - - - - 1.1 - 3.2 0.5 - - - 0.3 10 2.1 
6 2.7 0.3 2.4 - NA NA - 0.3 - - NA NA 2.1 0.8 NA NA 
Index (SD) 0.96 
(0.08) 
0.99 
(0.03) 
 0.98 
(0.06) 
1.00 
(0.02) 
 1.00 
(0.01) 
1.00 
(0.005) 
 0.99 
(0.04) 
0.99 
(0.02) 
 0.98 
(0.08) 
0.99 
(0.04) 
 0.91 
(0.11) 
0.94 
(0.09) 
 0.95 
(0.10) 
0.96 
(0.07) 
 0.90 
(0.14) 
0.95 
(0.08) 
*Pearson chi-square – significant differences between people with diabetes compared to people without diabetes. 
NA, not applicable (i.e., level not defined for HUI3 attribute) 
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Table 12  Multiple regression analyses on the HUI3 multi-attribute index for people with and 
without diabetes 
 All individuals  People with diabetes  Control 
individuals 
Dependent variable: Full model  Full model  Full model 
  ß p   ß p   ß p 
Intercept 0.86 <0.001   0.70 <0.001   0.90 <0.001 
                  
Sex                 
Men ref.     ref.     ref.   
Women -0.05 0.02  -0.07 0.06  -0.05 0.06 
                  
Age groups                 
20-39 years ref.     ref.     ref.   
40-60 years -0.09 0.001  -0.17 <0.001  -0.01 0.63 
60 years and above -0.22 <0.001  -0.34 <0.001  -0.10 0.002 
                  
Diabetes diagnosis                 
Control individuals ref.     NA     NA   
Patients with diabetes -0.16  <0.001    NA   NA  
                  
Level of education                 
Unfinished primary school ref.     ref.     ref.   
Finished primary school 0.01  0.70     0.04  0.27   -0.04 0.13 
Finished secondary school 0.00  0.99     0.005  0.91   -0.03 0.38 
University students 0.09  0.08     0.14  0.09   0.05 0.38 
Finished university -0.01  0.88     0.02  0.80   -0.03 0.40 
                
Marital status               
Single ref.     ref.     ref.  
Married 0.05  0.08     0.07  0.13   0.03 0.39 
Widowed 0.08  0.02     0.06  0.30   0.08 0.09 
Separated or divorced  0.05  0.36     0.03  0.76   0.04 0.50 
Cohabiting 0.09  0.53     0.02  0.91   0.09 0.67 
               
Employment status               
Unemployed/Not working1 ref.     ref.    ref.  
Employed 0.00  0.97     0.05  0.20   -0.06 0.05 
Retired or pensioner -0.04  0.23     0.04  0.48   -1.14 <0.001 
Housewife 0.07  0.02     0.17  <0.001   -0.04 0.24 
Student 0.07  0.18     0.18  0.06   -0.01 0.87 
                  
Region                 
Khartoum ref.     ref.     ref.   
Other states -0.02  0.20    -0.01  0.92    -0.03  0.13  
                  
R-Square 0.08     0.17     0.11   
Adjusted R-Square 0.08     0.14     0.07   
                  
Number of observations 750     375     375   
1Not working due to health problems 
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6 DISCUSSION   
The current climate of diminished health spending and increased demand for health services 
is forcing policy makers to either further cut back already inadequate health services, or to 
identify additional funding sources. This study has mainly focused on the economic and 
social burden of disease encountered by Sudanese patients with diabetes and their families. 
Several studies conducted in Sudan have investigated the clinical and epidemiological 
aspects of diabetes mellitus, but none of them has addressed the economic and social burden 
of the disease 28,76-79.  Unlike cost estimates derived from the data of individuals with diabetes 
identified from the general population or diabetes registers, this study design has the 
advantage of interviewing individuals face-to-face, thus obtaining relatively precise 
estimates of the cost of diabetes. This means that information about individuals’ costs and 
utilization patterns is collected directly, rather than estimated from aggregated data 24,80.  In 
this research, the burden of diabetes was explored in terms of the resources used by patients 
with diabetes, while the benefit was reflected by the degree of diabetes control, compared 
with healthcare costs of individuals without diabetes, and in relation to their health related-
quality of life. A low benefit in terms of poor metabolic control would be anticipated to 
associate with a high burden of diabetes in terms of years, and with a lower quality of life. 
6.1 Expenditure on patients and their families 
Our study assessing the healthcare costs associated with diabetes treatment and management 
showed that a four-fold increase in the cost of controlling diabetes occurred between 2005 
and 2013. This is probably due to increased utilization of health services and the use of newer 
expensive medications and interventions, while standards of living have also increased due 
to slight improvements in the economy. Paying for healthcare can be unfair in two different 
ways. It can expose families to large unexpected expenses which could not be foreseen and 
which have to be paid out-of-pocket at the moment of utilization of services, rather than being 
covered by some kind of prepayment. Additionally, healthcare payment imposes a regression 
phenomenon in which those least able to contribute pay proportionately more than those that 
are better off.  
The findings in our report demonstrate that the direct cost of diabetes care required 65% of 
the health expenditure of the whole family. Insulin constituted about one third of total 
diabetes care expenditure. Under such circumstances, people buy care even if it costs them 
their long-term livelihood, because medical expenses are often forced payments. In 
traditional economic analyses, poorer groups´ payment for healthcare is typically used as 
evidence of a willingness to pay, and this was proved in a previous study in a Sudanese 
household, such that they were willing to pay a reasonable fee for public health services with 
the assumption that the public health service provides good quality care 81. However, this 
considerable contribution by the family was not reciprocated with optimal healthcare of the 
patients, as reflected by sub-optimal glycaemic control in patients in both public and private 
practices. More detailed cost-benefit analyses need to be addressed. Few studies have been 
performed to assess the costs of diabetes in LIC countries82. A common experience for 
individuals with diabetes in low-income countries is the challenge of catastrophic medical 
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costs and a frequent lack of appropriate medications, despite possessing medical insurance. 
Similar to results reported elsewhere, out-of-pocket expenses of medications was found 
unaffordable for most households 83. In other low-and middle-income countries, individuals 
with diabetes are more likely to experience catastrophic medical spending and often do not 
possess appropriate medications to treat diabetes 83,84. 
Our analyses showed that health care costs were four times higher in people with diabetes, 
compared with those without diabetes.  These findings are consistent with results from other 
studies, in which similar data have been reported for cohorts of individuals with diabetes in 
Italy 85, the US 86, China 87, and Saudi Arabia, where this parameter was found to be up to 
ten times higher 88.   Other investigators have found that the presence of household members 
with chronic illnesses (such as diabetes) leads to increased health care expenditure and even 
impoverishment; for example, in Uganda, such households were found to be three times more 
likely to incur health care costs than other households. People living in LICs pay a larger 
share of total health expenditure, because they often lack access to health insurance and 
publicly-available medical services 21. The study indicates that the human and economic 
impact of diabetes may be far greater in low-income countries than in the industrialized 
world, where a diagnosis of diabetes is made much earlier, and where effective treatments 
are readily prescribed. For a low-income country such as Sudan, the economic costs of 
diabetes are huge, and the increasing prevalence of this disease poses a substantial threat to 
the country’s health care system and economy. 
Furthermore, a financial report from the Federal Ministry of Health in Sudan also supports 
our results by showing that the source of finance of health care expenditure for 84% of people 
is normal household expenditure, while, health insurance is the source for 6% of people; 
friends and relatives the source for 3% of people; the sale of belongings and assets the source 
for another 3% of people; and loans are the funding source for 3% of people. Almost 50% of 
respondents said that healthcare expenditure had had an impact on household income. To 
finance healthcare, 28% of respondents opted not to receive full treatment, 21% reduced their 
non-health expenditure in favour of healthcare, and 16% borrowed money 89. These data 
should be considered from the viewpoint that Sudan, as a low income country, spends almost 
6.5% of its GDP on health care, with an out-of-pocket share to cover health costs of about 
70%, or 84 USD per capita, and 22% through GGHE, translating to 27 USD per capita, or 
8.2% of general government expenditure (GGE).  
6.2 Impact on patients and their families 
Various socioeconomic and educational characteristics influence the prognosis of individuals 
with diabetes. Economic variables include direct non-healthcare costs, such as a family’s 
expenditure on special food, physical activities undertaken because of the child’s diabetes, 
and informal care provided by the primary and other caregivers. The latter has been defined 
as the performance of tasks that help maintain or enhance the patient’s health, and which are 
carried out by non-professional caregivers 90. A high rate of illiteracy amongst mothers may 
contribute to impaired care of a child with diabetes. In addition, the illiteracy of fathers could 
hamper good financial support to a child with diabetes and may keep patients away from 
hospitals until their condition is much more severe. Another study conducted in Egypt 
highlights the fact that low levels of educational attainment can limit the extent to which 
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patients can manage their problems associated with diabetes 91.  The poor metabolic control 
exhibited in this study was associated with a negative impact on educational attainment and 
school performance of the child with diabetes. Because of inadequate and intermittent 
treatment, most children with diabetes were in poor health, and frequent hospital admissions 
prevented them from attending school. Another study has reported a negative correlation 
between education and level of metabolic control of type 1 diabetes 92. Of the newly 
diagnosed children with diabetes in Sudan, 81% presented to hospitals with diabetic 
ketoacidosis 93.  
A crucial observation from our study was that diabetes had a profound effect on the social 
and economic circumstances of both patients and their families. Compared to families that 
had no members with diabetes, the presence of diabetes in families had effects on schooling, 
training, and employment. These findings are consistent with observations of the effects of 
diabetes in a cohort in the United States 94, and are in agreement with studies demonstrating 
the negative effects of hypoglycaemic episodes on economic productivity 95. Other recent 
studies have reported similar findings 96-98. Results from a systematic review reported that 
diabetes had a significant negative impact on the ability-to-work outcomes considered 36. Since 
our results show the impact of diabetes on economically important activities such as farming, 
this is potentially of great importance to Sudan, firstly because a significant proportion of the 
population relies on subsistence farming, and secondly because agriculture contributes a 
significant amount to the country’s total exports. Clearly improvements in the clinical 
management of diabetes at the local level will not only lead to improved quality of life for  
individuals with diabetes and their families, but will also lead to socioeconomic 
improvements at both the community and local levels. 
6.3 Quality of diabetes care   
The results from this study, and also those of others 33,99,100, indicate that a good quality of 
diabetes care has yet to be achieved in Sudan. In our studies of both type 1 diabetes in children, 
and of adults with type 2 diabetes, we found that more than two thirds of the patients were not 
optimally controlled, regardless of whether they were attending private or public health clinics. 
This economic burden has generally not translated into optimum diabetes care in either private 
or public practices, and can be considered as a depletion of family resources and an inefficient 
healthcare delivery system.   
To maintain a healthy quality of life, patients with diabetes must have access to appropriate 
medication, quality care and good medical advice. A study by Gilmer et al. reported a 
relationship between improved glycaemic control and decreasing healthcare costs 101. The 
American Diabetes Association (ADA), for example, recommends achieving HbA1c levels of 
<7.0% 102, whereas the American Association of Clinical Endocrinologists (AACE) 
recommends  levels of <6.5%.  Maintenance of such glycaemic levels will significantly reduce 
complications in both type 1 and type 2 diabetes. Results from the United Kingdom prospective 
diabetes study (UKPDS) demonstrated that there is no HbA1c threshold at which further 
lowering does not reduce the risk of complications until the normal range (<6.0%) is reached 
103.  Glycaemic control can be viewed as an intermediary outcome indicator of effectiveness of 
treatment, as it is known to be related to the long-term prognosis of the disease. Additionally, 
it is likely that poor glycaemic control is a consequence of failure to address other risk factors, 
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such as insufficient awareness of lifestyle risks. A low benefit in terms of poor metabolic 
control would be anticipated to associate with a high burden of diabetes in terms of years, and 
with a lower quality of life, expressed as Disability-Adjusted Life Years (DALYs) 104. 
Improved glycaemic control is also associated with substantial quality-of-life and health 
economic benefits 105. Favourable health economic outcomes include higher retained 
employment rates, greater productive capacity, less absenteeism and fewer restricted activity 
days 106.   
While intensive diabetes therapy is more expensive, the cost of treating diabetes-related 
complications is substantially reduced, and the amount of time free from complications is 
increased. For example, using outcome data from the UKPDS trial, it has been shown for 1997 
that intensive therapy costs rose by USD 1 138 per patient, while complication costs were 
diminished by USD 1597 107.  
As indicated previously, more than 75% of patients with either type 1 or type 2 diabetes never 
self-monitor their blood glucose levels 99. In diabetes care, the regularity of blood glucose 
control may indicate the quality of the process of care. In our study, Home Blood Glucose 
Monitoring (HBGM) was only performed by one out of ten adult patients.  HbA1c is the ideal 
way to monitor blood glucose when the facilities and resources are available, one practical 
consideration in Africa being maintaining the correct ambient air temperature 108. However, for 
most people with diabetes in Africa, this option is infeasible.  Even when available, HbA1c is 
measured in less than 5% of patients 109-112.  Fasting blood glucose is probably the most 
affordable means of monitoring people with diabetes, although even this might not be available 
110. Random blood glucose is the most common means of monitoring 110,111, which can be 
helpful in people with type 2 diabetes if the time of the last meal is also recorded. Urine glucose 
measurements can be useful in identifying people with blood glucose levels that require 
immediate attention. The current poor availability and lack of use of methods for monitoring 
blood glucose means that very few people with diabetes in Africa are likely to achieve normal 
levels of glycosylated haemoglobin. 
One of the main factors that encouraged the private provision of health services was the 
perceived deterioration of the quality of services provided by public healthcare facilities 81.  In 
addition, the introduction of user fees in the public domain providing health services made the 
ratio of quality/cost more favourable for the private sector, as the higher user charges in the 
private sector were accompanied by its higher quality.  No studies of the negative impacts of 
the user charge policy on equity have been performed in Sudan, despite long- standing concerns 
and renewed debate about its effects.  
6.4 Impact on health–related quality of life  
A variety of developments in the Sudanese society, including economic, political and 
ideological changes, have profoundly influenced health care in Sudan. Furthermore, social 
phenomena such as immigration of refugee populations, and altering dietary habits in various 
parts of the population, have also impacted upon the prevalence and treatment of diabetes, a 
disease which is directly related to nutrition. Our study confirmed the negative impact of 
diabetes on HRQoL in people with diabetes. Other findings from a case control study are in 
line with our results showing that Bangladeshi patients with diabetes were more likely to report 
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problems in all dimensions than controls, with the largest effect observed in the dimensions 
‘self-care’ and ‘mobility’ 113. Our study is in line with results from population-based studies 
from Korea and Germany 114,115. 
In our report, pain was the most affected attribute, since people with diabetes reported having 
moderate to severe pain which affected performance significantly more often than control 
individuals. This is consistent with results showing that diabetic neuropathy in adults with type 
1 or type 2 diabetes is both associated with a significantly reduced quality of life, and also a 
substantial economic burden both for society and for health insurance 115,116.  Pain has profound 
consequences for the quality of life of patients, their families, and their social and professional 
environment. Only a holistic clinical approach will successfully improve the patient’s condition 
117.  
Additionally, diabetes leads to a range of impairments in vision, with blindness in a few patients 
118. While the prevalence and incidence of sight-threatening diabetic retinopathy and other sight 
defects in developed countries is well documented 119,116, there is little published data 
concerning this situation in sub-Saharan Africa 120. 
Emotions constituted another source of heterogeneity in respondents with diabetes, with 
significant levels of ‘unhappiness’ more common amongst people with diabetes. Depression is 
a well-documented feature in these patients 51,74,121, and it is of importance to assess emotional 
attributes when determining disease progression outcomes in people with diabetes. 
Our findings also showed differences amongst respondents for the attribute hands.  Although 
most respondents reported no problems in using their hands, some experienced limitations in 
the use of hands and fingers, and were unable to perform certain tasks without help. Several 
studies have shown that various musculoskeletal disorders and hand lesions occur more 
frequently among people with diabetes 122-124.  
In the age group 40 years of age or above, the HUI3 multi-attribute index was significantly 
different in people with diabetes. Such differences have been shown previously 125-128. It 
appears that rural populations show lower levels of HRQoL compared with urban areas. 
However, we found no difference in HRQOL between Khartoum and other regions. Estimates 
of rural differentiation have shown variable results, even in studies using HUI3 129. 
6.5 Methodological considerations 
Data were collected by a study team which was trained by the principle investigator (HE), one 
research assistant, and three data collectors. This team was hired from the Ministry of health 
and their selection was based on their experience with interview procedures. They underwent 
a four-week training, during which they were taught about the study protocol and research 
ethics, and trained to perform the interviews. The interviewers and interviewees were from the 
same socioeconomic category, which facilitated a common understanding of the questions. 
One limitation of this study is the possibility of under-reporting of family income which would 
have caused an overestimation of the percentage of income spent on healthcare. This was most 
likely to have occurred in the high-income group. Secondly, we did not have data from a 
comparable population to indicate general family healthcare expenses. The major objective of 
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the study was to assess the direct cost of treating a chronic disease without reporting 
complications, which would be higher than that of the cost of general healthcare. Data for 26 
percent of the children in study I were missing with regards to blood glucose monitoring at 
home, which makes the data less valid for the whole population of children in the study. In 
relation to our findings, it can be assumed that it is more likely that those not reporting any 
monitoring of blood glucose levels are those with diabetes that is not well-controlled. If such 
is the case, our findings would overestimate the already low level of diabetic control.  
There is a potential for recall bias about costs associated with diabetes care and 
hospitalization, as well as a possible underestimation of the costs of inpatient visits and 
medication in the study population, because subjects were recruited from those receiving 
ambulatory care. Patients with chronic complications of diabetes are usually seen in tertiary 
care. Moreover, some patients’ recall of cost for treatments may not be adequate because of 
illiteracy or because the medications were bought by others in their household. Because the 
recruitment of control subjects was based on recommendations by diabetes patients, there is 
a possibility that this sample is biased. A more careful selection strategy would have included 
participants either from the community or individuals without diabetes from the rolls of a 
hospital.   However, this was not done in the present study. A strength of the present study is 
that the protocol used for the selection of matched control subjects ensured that a suitable 
control group was selected based on demographic factors. Another strength of the study was 
the survey instrument used, which was developed by the IDF, and this strengthens the 
applicability of the findings to other settings. Furthermore, the guidelines from the IDF 
contain instructions for coding alongside each of the questions.  
The research protocol and sampling process employed in our study I and II were designed to 
avoid any bias in the results, although some limitations should be recognized. We included 
only households belonging to one metropolitan area, and so it may not be possible to apply 
the results to the whole country. However, due to the representative nature of the sample, the 
results may be applicable to other urban areas, and thus it is anticipated that the study reflects 
actual health service participation for a significant proportion of the Sudanese population. 
Since inpatient service use is infrequent, a much larger sample would be needed to explore 
hospitalization and its costs. A separate study in a high-income country employed data from 
a large retrospective, population-based cohort of Swedish patients with type 2 diabetes to 
assess the extent of medical resource usage, and reported that the greatest economic burden 
was the elevated rate of hospitalization (12–16%) in this patient population 130. For study III 
and IV samples were recruited from outpatient diabetes clinics in four separate states from 
different parts of Sudan. These studies demonstrated that no differences were observed 
between Khartoum and these other regions with respect to HRQoL. Since the attributes 
examined in studies III & IV appeared to be consistent between Khartoum and the other four 
states, this suggests that it may be possible to extend the results obtained for urban areas 
described in study I and II to these other non-urban regions of the country. 
In addition, economic assessment studies should be based on standard research methods and 
reliable data to ensure validity and comparability of results. Finally, areas of economic research 
should be broadened, such as studying issues related to the prevention of diabetes. Patients and 
their families need to be involved and made aware of the advantages of controlling the disease 
to avoid the consequences of its complications. 
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7 CONCLUSIONS AND RECOMMENDATIONS 
Diabetes is a costly disease in Sudan, with childhood diabetes consuming a major part of the 
total income of a family that has a child with diabetes. People with diabetes were found to have 
much higher total annual costs for medical services, and also described a higher proportion of 
adverse social effects on themselves and on other family members, and confirms the negative 
impact of diabetes on HRQoL compare to those without diabetes. 
The economic burden on Sudanese people with type 1 and type 2 diabetes, and on their families, 
is increasing. Sources of medical expenditure include the individual with the disease, which 
may be chronic, but also inpatient care and the reduced economic status and education level of 
the head of the household. Diabetes care involves long-term routine clinical visits to the clinic, 
regular testing and medications, while households have limited flexibility to respond to the cost 
of unexpected hospitalization or other illness episodes. Meanwhile, the Sudanese health care 
system is ill-equipped to meet this burden and its complications.  
We found that over two thirds of patients attending private or public health clinics were not 
optimally controlled. This indicates that high quality diabetes care has yet to be achieved, 
despite the fact that patient OOP health care expenditure is far higher than government 
expenditure, which provides only one fifth of total health expenditure. However, this amount 
is still too small to purchase adequate quality services.  
The prevalence of diabetes in Sudan is increasing, and this study has addressed the economic 
and social magnitude of this disease. It has revealed the ineffectiveness in the care and 
management of type 1 and type 2 diabetes that results in poor glycaemic control, and 
consequent increased morbidity and reduced quality of life. A number of measures therefore 
need to be urgently implemented, including making diabetes care available and accessible to 
those who need it, particularly in public healthcare facilities. In order to encourage vulnerable 
families in the control of diabetes and its complications, alternative funds should be created to 
finance quality diabetes care in public healthcare facilities. This would seem reasonable, since 
there are user charges for health services in public utilities, including those for diabetes. Those 
involved in diabetes care should be aware of what drives costs, and economic research is 
needed to assess both the impact of the growing number of available interventions, as well as 
how economic factors such as income level, education, lifestyle selection, and awareness of 
the importance of control are associated with diabetes and its complications.  
The proper treatment of diabetes is not costly, but not treating diabetes properly is very costly, 
and economic studies demonstrate that interventions used to prevent and control diabetes may 
differ greatly in terms of costs per health outcome gained. Health providers and policymakers 
should use this information in making clinical and policy decisions in order to use resources 
efficiently. Efforts are needed to improve the quality of economic studies and to expand 
economic research to new areas in the future.  
Our findings show that additional public resources need to be mobilized to deliver universal 
health and health insurance coverage. While the population’s enrolment into the National 
Health Insurance System (NHIS) is critical in this respect, an effective health delivery system 
is fundamental for the population to benefit from the promised entitlement. These two systems 
should go hand-in-hand to achieve better health outcomes. While the NHIS is in its early stages, 
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reforms are needed to improve coverage and the program’s effectiveness. Sudan has come a 
long way and has embarked on an ambitious goal that many larger countries have yet to 
establish. 
From the findings in this study, I propose some possible actions to curb the burden of diabetes 
in LMICs: 
 
 Initiate or strengthen a visible and viable operation policy and strategy for diabetes in 
the National NCDs plan. The strategic framework is to guide the funding, planning 
organization, provision, and monitoring and evaluation of services of people with or at 
risk of diabetes. 
 
 Integrate essential standards of managing diabetes into primary health care.  
 
 Provision of the necessary socio-economic, medical and social support for families with 
a child with diabetes, and for families of patients with diabetes with chronic 
complications. 
 
 Continuous educational diabetes programs for patients with diabetes and their families, 
to promote diabetes self-management education and support.  
 
 Provision of insulin and other anti-diabetic drugs, as well as blood glucose monitoring 
equipment, should be encouraged at a low cost. 
 
 Improve primary care services for people with diabetes to reduce the cost of diabetes 
care at higher levels, such as control of blood pressure and blood lipids. 
 
Implementation of inexpensive and easy to use interventions can reduce the huge economic 
burden of diabetes. Many of these interventions are cost-effective, and in some cases cost-
saving, in LICs. 
 
This thesis illustrates the fact that diabetes care in Sudan needs to be urgently improved. An 
important feature of this should be the way that various aspects of diabetes care are funded. In 
addition, any changes should also be supported by further research in the following areas: 
improvements in the quality of life of diabetes patients, both with and without complications, 
should be assessed by cost-analysis studies; improved mechanisms of service delivery should 
be identified by studies evaluating health care provision for diabetes in relation to cost; finally, 
coping behaviours exhibited by parents of children with diabetes, and by people with diabetes, 
should be studied, together with promoting the awareness of patients’ and families’ roles in 
controlling the disease and its complications, in order to gain a greater insight into how the 
impact of this disease might be reduced.
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